General
Preferred name
BUTABARBITAL
Synonyms
secbutabarbital ()
BUTABARBITAL SODIUM ()
Unicelles ()
Sec-butobarbitone ()
Medarsed ()
Nilox ()
Secbutobarbitone ()
Butatab ()
Butabarbital ciii ()
Butabarbital ()
Butabarbital sodium salt ()
Butisol Sodium ()
Sodium Butabarbital ()
Loubarb ()
Sarisol No. 1 ()
Mebutal ()
Sarisol ()
Butabarb ()
Buticaps ()
NSC-11778 ()
Sarisol No. 2 ()
Secbutabarbital Sodium ()
Astrudion ()
Butalan ()
Butabarbital-d5 ()
Butabarbital-d5 (CRM) ()
Butabarbital (CRM) ()
P&D ID
PD010154
CAS
1135-61-1
125-40-6
3330-61-8
1215565-64-2
Tags
natural product
drug
available
Approved by
FDA
First approval
1939
Drug Status
illicit
approved
Drug indication
Sedative-Hypnotic
Insomnia
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Butabarbital is a prescription barbiturate sedative. It is used in relatively few countries due to its potential for abuse and dangerous interaction in combination with alcohol.
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
11
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Guide to Pharmacology
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
46
Properties
(calculated by RDKit )
Molecular Weight
212.12
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
1
Aromatic Ring Count
0
cLogP
0.79
TPSA
75.27
Fraction CSP3
0.7
Chiral centers
1.0
Largest ring
6.0
QED
0.68
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Therapeutic Class
Antianxiety Agents
Source data